IGF1R and neoplasm: Moreover, the mutation frequency in the corresponding normal sample was comparable to that in the tumor sample and patient P83 was affected by a germline mutation in the TK-domain of ERBB3 but a somatic mutation in the ligand-binding domain of IGF1R (Figure 1B, 1D).